{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:50:45Z","timestamp":1788846645481,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA193193"],"award-info":[{"award-number":["CA193193"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA218398"],"award-info":[{"award-number":["R01 CA218398"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA122061"],"award-info":[{"award-number":["CA122061"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5K12 HL137940-02"],"award-info":[{"award-number":["5K12 HL137940-02"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R38-HL143612"],"award-info":[{"award-number":["R38-HL143612"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1 CA189828-07S1"],"award-info":[{"award-number":["UG1 CA189828-07S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jval.2021.06.012","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T16:00:23Z","timestamp":1628438423000},"page":"1820-1827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Inclusion of Patient-Reported Outcomes in Adolescent and Young Adult Phase III Therapeutic Trials: An Analysis of Cancer Clinical Trials Registered on ClinicalTrials.gov"],"prefix":"10.1016","volume":"24","author":[{"given":"Amy M.","family":"Berkman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karly M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Siembida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Salsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2021.06.012_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2021.06.012_bib2","doi-asserted-by":"crossref","first-page":"d4163","DOI":"10.1136\/bmj.d4163","article-title":"How should we define health?","volume":"343","author":"Huber","year":"2011","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jval.2021.06.012_bib3","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s11136-019-02214-9","article-title":"A\u00a0systematic review of quality of life research in medicine and health sciences","volume":"28","author":"Haraldstad","year":"2019","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.jval.2021.06.012_bib4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1634\/theoncologist.2018-0590","article-title":"Patient-reported toxicities during chemotherapy regimens in current clinical practice for early breast cancer","volume":"24","author":"Nyrop","year":"2019","journal-title":"Oncologist"},{"issue":"32","key":"10.1016\/j.jval.2021.06.012_bib5","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1200\/JCO.2007.11.3324","article-title":"Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks","volume":"25","author":"Bruner","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"34","key":"10.1016\/j.jval.2021.06.012_bib6","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1200\/JCO.2012.42.5967","article-title":"Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology","volume":"30","author":"Basch","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.jval.2021.06.012_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrclinonc.2017.153","article-title":"Patient-reported outcomes in cancer care - hearing the patient voice at greater volume","volume":"14","author":"LeBlanc","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jval.2021.06.012_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cct.2015.04.004","article-title":"Inclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials.gov (2007-2013)","volume":"43","author":"Vodicka","year":"2015","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"10.1016\/j.jval.2021.06.012_bib9","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1200\/JOP.2015.009084","article-title":"Low enrollment of adolescents and young adults onto cancer trials: insights from the community Clinical Oncology Program","volume":"12","author":"Roth","year":"2016","journal-title":"J\u00a0Oncol Pract"},{"issue":"6","key":"10.1016\/j.jval.2021.06.012_bib10","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/cam4.2891","article-title":"Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: a comparative analysis by treatment site and era","volume":"9","author":"Roth","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.jval.2021.06.012_bib11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/EDBK_156686","article-title":"The role of clinical trial participation in cancer research: barriers, evidence, and strategies","volume":"35","author":"Unger","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"10.1016\/j.jval.2021.06.012_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27426","article-title":"Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012-2013 in the United States","volume":"66","author":"Parsons","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.jval.2021.06.012_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40124-015-0075-y","article-title":"The clinical trials gap for adolescents and young adults with cancer: recent progress and conceptual framework for continued research","volume":"3","author":"Freyer","year":"2015","journal-title":"Curr Pediatr Rep"},{"issue":"5","key":"10.1016\/j.jval.2021.06.012_bib14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/cncr.32675","article-title":"Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: identifying opportunities for intervention","volume":"126","author":"Siembida","year":"2020","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jval.2021.06.012_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/jnci\/djy140","article-title":"A\u00a0reappraisal of sex-specific cancer survival trends among adolescents and young adults in the United States","volume":"111","author":"Liu","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.jval.2021.06.012_bib16","first-page":"443","article-title":"Cancer statistics for adolescents and young adults, 2020","volume":"70","author":"Miller","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"10.1016\/j.jval.2021.06.012_bib17","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","article-title":"What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials","volume":"32","author":"Kotronoulas","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.jval.2021.06.012_bib18","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1200\/JCO.2012.47.3173","article-title":"Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience study","volume":"31","author":"Smith","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"10.1016\/j.jval.2021.06.012_bib19","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/cncr.31985","article-title":"Lasting effects of cancer and its treatment on employment and finances in adolescent and young adult cancer survivors","volume":"125","author":"Ketterl","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jval.2021.06.012_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/jayao.2017.0046","article-title":"Patient-reported health-related quality-of-life assessment at the point-of-care with adolescents and young adults with cancer","volume":"7","author":"Henderson","year":"2018","journal-title":"J\u00a0Adolesc Young Adult Oncol"},{"issue":"4","key":"10.1016\/j.jval.2021.06.012_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11764-018-0684-x","article-title":"Sexual function in adolescent and young adult cancer survivors-a population-based study","volume":"12","author":"Olsson","year":"2018","journal-title":"J\u00a0Cancer Surviv"},{"key":"10.1016\/j.jval.2021.06.012_bib22","first-page":"1","article-title":"Body image concerns of young adult cancer survivors: a brief report","author":"Vani","year":"2020","journal-title":"J\u00a0Psychosoc Oncol"},{"issue":"6","key":"10.1016\/j.jval.2021.06.012_bib23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/cncr.31862","article-title":"Fertility counseling before cancer treatment and subsequent reproductive concerns among female adolescent and young adult cancer survivors","volume":"125","author":"Young","year":"2019","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jval.2021.06.012_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jayao.2019.0069","article-title":"System performance indicators for adolescent and young adult cancer care and control: a scoping review","volume":"9","author":"Rae","year":"2020","journal-title":"J\u00a0Adolesc Young Adult Oncol"},{"issue":"1","key":"10.1016\/j.jval.2021.06.012_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27486","article-title":"Understanding care and outcomes in adolescents and young adult with cancer: a review of the AYA HOPE study","volume":"66","author":"Smith","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jval.2021.06.012_bib28","series-title":"Food and Drug Administration, Amendments Act of 2007","year":"2007"},{"issue":"2","key":"10.1016\/j.jval.2021.06.012_bib29","first-page":"449","article-title":"Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia","volume":"25","author":"Sands","year":"2017","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.jval.2021.06.012_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/jayao.2011.0033","article-title":"Health-related quality of life of young adult survivors of childhood cancer: a review of qualitative studies","volume":"1","author":"Nightingale","year":"2011","journal-title":"J\u00a0Adolesc Young Adult Oncol"},{"key":"10.1016\/j.jval.2021.06.012_bib31","series-title":"RFA-CA-20-027, Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Option)","year":"2021"},{"issue":"10","key":"10.1016\/j.jval.2021.06.012_bib32","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/0277-9536(95)00114-M","article-title":"Quality of life assessment in pediatric oncology: a retrospective review of phase III reports","volume":"41","author":"Bradlyn","year":"1995","journal-title":"Soc Sci Med"},{"issue":"2","key":"10.1016\/j.jval.2021.06.012_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40271-017-0279-z","article-title":"Symptom monitoring in pediatric oncology using patient-reported outcomes: why, how, and where next","volume":"11","author":"Leahy","year":"2018","journal-title":"Patient"},{"key":"10.1016\/j.jval.2021.06.012_bib34","article-title":"Patient reported outcomes in pediatric cancer registration trials: a U.S. Food and Drug Administration perspective [published online Apr 30, 2021]","author":"Murugappan","year":"2021","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.jval.2021.06.012_bib35","first-page":"2921","article-title":"Instruments to measure anxiety in children, adolescents, and young adults with cancer: a systematic review","volume":"25","author":"Lazor","year":"2017","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.jval.2021.06.012_bib36","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s11136-017-1520-x","article-title":"Systematic review of the health-related quality of life issues facing adolescents and young adults with cancer","volume":"26","author":"Sodergren","year":"2017","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.jval.2021.06.012_bib37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0959-8049(00)00007-1","article-title":"Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group","volume":"36","author":"de Haes","year":"2000","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.jval.2021.06.012_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005650-199902000-00003","article-title":"The PedsQL: measurement model for the pediatric quality of life inventory","volume":"37","author":"Varni","year":"1999","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.jval.2021.06.012_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.jval.2021.06.012_bib40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/1359105309103580","article-title":"The PedsQL 4.0 Generic Core Scales Young Adult Version: feasibility, reliability and validity in a university student population","volume":"14","author":"Varni","year":"2009","journal-title":"J\u00a0Health Psychol"},{"issue":"10","key":"10.1016\/j.jval.2021.06.012_bib41","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/cncr.33416","article-title":"The importance of a collaborative health-related quality of life measurement strategy for Adolescents and Young Adults with Cancer","volume":"127","author":"Husson","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jval.2021.06.012_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12955-015-0312-7","article-title":"Development and validation of the BRIGHTLIGHT Survey, a patient-reported experience measure for young people with cancer","volume":"13","author":"Taylor","year":"2015","journal-title":"Health Qual Life Outcomes"},{"issue":"22","key":"10.1016\/j.jval.2021.06.012_bib44","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1002\/cncr.33155","article-title":"Optimizing the measurement of health-related quality of life in adolescents and young adults with cancer","volume":"126","author":"Salsman","year":"2020","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.jval.2021.06.012_bib45","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11136-018-2073-3","article-title":"Determining a transitional scoring link between Promis(R) pediatric and adult physical health measures","volume":"28","author":"Tulsky","year":"2019","journal-title":"Qual Life Res"},{"issue":"11","key":"10.1016\/j.jval.2021.06.012_bib46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/djaa016","article-title":"Validity and reliability of the pediatric patient-reported outcomes - common terminology criteria for adverse events","volume":"112","author":"Reeve","year":"2020","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.jval.2021.06.012_bib47","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jpainsymman.2016.11.006","article-title":"Cognitive interview-based validation of the patient-reported outcomes version of the common terminology criteria for adverse events in adolescents with cancer","volume":"53","author":"Reeve","year":"2017","journal-title":"J\u00a0Pain Symptom Manag"},{"issue":"2","key":"10.1016\/j.jval.2021.06.012_bib48","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/S1470-2045(19)30790-9","article-title":"International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium","volume":"21","author":"Coens","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521016405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301521016405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:09:27Z","timestamp":1778519367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301521016405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1098301521016405"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2021.06.012","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inclusion of Patient-Reported Outcomes in Adolescent and Young Adult Phase III Therapeutic Trials: An Analysis of Cancer Clinical Trials Registered on ClinicalTrials.gov","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2021.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}